56 related articles for article (PubMed ID: 15136062)
1. L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty.
George J; Shmuel SB; Roth A; Herz I; Izraelov S; Deutsch V; Keren G; Miller H
Atherosclerosis; 2004 Jun; 174(2):323-7. PubMed ID: 15136062
[TBL] [Abstract][Full Text] [Related]
2. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina.
Segev A; Strauss BH; Witztum JL; Lau HK; Tsimikas S
Am Heart J; 2005 Nov; 150(5):1007-14. PubMed ID: 16290986
[TBL] [Abstract][Full Text] [Related]
3. Eptifibatide does not influence lymphocyte activation and CRP levels in patients with undergoing coronary angioplasty.
Finkelstein A; Izraelov S; Roth A; Ben-Shmuel S; Keren G; Miller H; George J
Int J Cardiovasc Intervent; 2004; 6(3-4):107-9. PubMed ID: 16146902
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
5. Effect of short-term administration of high dose L-arginine on restenosis after percutaneous transluminal coronary angioplasty.
Shiraki T; Takamura T; Kajiyama A; Oka T; Saito D
J Cardiol; 2004 Jul; 44(1):13-20. PubMed ID: 15334880
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
[TBL] [Abstract][Full Text] [Related]
7. Effect of intensive atorvastatin therapy on periprocedural PDCD4 expression in CD4+ T lymphocytes of patients with unstable angina undergoing percutaneous coronary intervention.
Su Q; Li L; Liu Y; Zhou Y; Wang J; Sun Y
Cardiology; 2014; 127(3):169-75. PubMed ID: 24434439
[TBL] [Abstract][Full Text] [Related]
8. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.
Saleh N; Tornvall P
Atherosclerosis; 2007 Dec; 195(2):374-8. PubMed ID: 17126343
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications.
Monaco C; Crea F; Niccoli G; Summaria F; Cianflone D; Bordone R; Bellomo G; Maseri A
Eur Heart J; 2001 Sep; 22(17):1572-7. PubMed ID: 11492986
[TBL] [Abstract][Full Text] [Related]
10. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
[TBL] [Abstract][Full Text] [Related]
12. Different patterns of interleukin-6 and von Willebrand factor antigen changes after coronary stenting in unstable versus stable angina.
Spaziani D; De Servi S; Morelli B; D'Urbano M; Vandoni P; Mariani G; Passoni F; Cafiero F
Ital Heart J; 2002 Oct; 3(10):593-7. PubMed ID: 12478817
[TBL] [Abstract][Full Text] [Related]
13. The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention.
Saltzman AJ; Mehran R; Hooper WC; Moses JW; Weisz G; Collins MB; Lansky AJ; Kreps EM; Leon MB; Stone GW; Dangas G
J Invasive Cardiol; 2010 Jan; 22(1):2-6. PubMed ID: 20048389
[TBL] [Abstract][Full Text] [Related]
14. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
[TBL] [Abstract][Full Text] [Related]
15. Effects of celecoxib on restenosis after coronary intervention and evolution of atherosclerosis (Mini-COREA) trial: celecoxib, a double-edged sword for patients with angina.
Kang HJ; Oh IY; Chung JW; Yang HM; Suh JW; Park KW; Kwon TK; Lee HY; Cho YS; Youn TJ; Koo BK; Kang WY; Kim W; Rha SW; Bae JH; Chae IH; Choi DJ; Kim HS
Eur Heart J; 2012 Nov; 33(21):2653-61. PubMed ID: 22408034
[TBL] [Abstract][Full Text] [Related]
16. Differences in human antioxidized LDL autoantibodies in patients with stable and unstable angina.
Fernandes JL; Orford JL; Garcia C; Coelho OR; Gidlund M; Blotta MH
J Autoimmun; 2004 Dec; 23(4):345-52. PubMed ID: 15571928
[TBL] [Abstract][Full Text] [Related]
17. Comparison of acute vessel wall injury after self-expanding stent and conventional balloon-expandable stent implantation: a study with optical coherence tomography.
Shin ES; Garcia-Garcia HM; Okamura T; Wykrzykowska JJ; Gonzalo N; Shen ZJ; van Geuns RJ; Regar E; Serruys PW
J Invasive Cardiol; 2010 Sep; 22(9):435-9. PubMed ID: 20814052
[TBL] [Abstract][Full Text] [Related]
18. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris.
Doo YC; Han SJ; Lee JH; Cho GY; Hong KS; Han KR; Lee NH; Oh DJ; Ryu KH; Rhim CY; Lee KH; Lee Y
Am J Cardiol; 2004 Mar; 93(5):554-8. PubMed ID: 14996578
[TBL] [Abstract][Full Text] [Related]
19. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).
Assali AR; Moustapha A; Sdringola S; Denktas AE; Willerson JT; Holmes DR; Smalling RW
Am J Cardiol; 2006 Sep; 98(6):729-33. PubMed ID: 16950172
[TBL] [Abstract][Full Text] [Related]
20. Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease.
Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
Int J Cardiol; 2006 Nov; 113(2):167-73. PubMed ID: 16338010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
